226 related articles for article (PubMed ID: 33539964)
1. Back where it belongs: 11β-hydroxyandrostenedione compels the re-assessment of C11-oxy androgens in steroidogenesis.
Barnard L; du Toit T; Swart AC
Mol Cell Endocrinol; 2021 Apr; 525():111189. PubMed ID: 33539964
[TBL] [Abstract][Full Text] [Related]
2. The 11β-hydroxyandrostenedione pathway and C11-oxy C
du Toit T; Swart AC
J Steroid Biochem Mol Biol; 2020 Feb; 196():105497. PubMed ID: 31626910
[TBL] [Abstract][Full Text] [Related]
3. The 11β-hydroxysteroid dehydrogenase isoforms: pivotal catalytic activities yield potent C11-oxy C
Gent R; du Toit T; Bloem LM; Swart AC
J Steroid Biochem Mol Biol; 2019 May; 189():116-126. PubMed ID: 30825506
[TBL] [Abstract][Full Text] [Related]
4. Profiling adrenal 11β-hydroxyandrostenedione metabolites in prostate cancer cells, tissue and plasma: UPC
du Toit T; Bloem LM; Quanson JL; Ehlers R; Serafin AM; Swart AC
J Steroid Biochem Mol Biol; 2017 Feb; 166():54-67. PubMed ID: 27345701
[TBL] [Abstract][Full Text] [Related]
5. Inefficient UGT-conjugation of adrenal 11β-hydroxyandrostenedione metabolites highlights C11-oxy C
du Toit T; Swart AC
Mol Cell Endocrinol; 2018 Feb; 461():265-276. PubMed ID: 28939401
[TBL] [Abstract][Full Text] [Related]
6. Analysis of 52 C
du Toit T; van Rooyen D; Stander MA; Atkin SL; Swart AC
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Sep; 1152():122243. PubMed ID: 32593151
[TBL] [Abstract][Full Text] [Related]
7. The in vitro metabolism of 11β-hydroxyprogesterone and 11-ketoprogesterone to 11-ketodihydrotestosterone in the backdoor pathway.
van Rooyen D; Gent R; Barnard L; Swart AC
J Steroid Biochem Mol Biol; 2018 Apr; 178():203-212. PubMed ID: 29277707
[TBL] [Abstract][Full Text] [Related]
8. 11α-Hydroxyprogesterone, a potent 11β-hydroxysteroid dehydrogenase inhibitor, is metabolised by steroid-5α-reductase and cytochrome P450 17α-hydroxylase/17,20-lyase to produce C11α-derivatives of 21-deoxycortisol and 11-hydroxyandrostenedione in vitro.
Gent R; du Toit T; Swart AC
J Steroid Biochem Mol Biol; 2019 Jul; 191():105369. PubMed ID: 31039398
[TBL] [Abstract][Full Text] [Related]
9. 11β-hydroxyandrostenedione, the product of androstenedione metabolism in the adrenal, is metabolized in LNCaP cells by 5α-reductase yielding 11β-hydroxy-5α-androstanedione.
Swart AC; Schloms L; Storbeck KH; Bloem LM; Toit Td; Quanson JL; Rainey WE; Swart P
J Steroid Biochem Mol Biol; 2013 Nov; 138():132-42. PubMed ID: 23685396
[TBL] [Abstract][Full Text] [Related]
10. C11-hydroxy and C11-oxo C
Gent R; Van Rooyen D; Atkin SL; Swart AC
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203272
[TBL] [Abstract][Full Text] [Related]
11. CYP17A1 exhibits 17αhydroxylase/17,20-lyase activity towards 11β-hydroxyprogesterone and 11-ketoprogesterone metabolites in the C11-oxy backdoor pathway.
van Rooyen D; Yadav R; Scott EE; Swart AC
J Steroid Biochem Mol Biol; 2020 May; 199():105614. PubMed ID: 32007561
[TBL] [Abstract][Full Text] [Related]
12. Adrenal C11-oxy C
Barnard L; Gent R; van Rooyen D; Swart AC
J Steroid Biochem Mol Biol; 2017 Nov; 174():86-95. PubMed ID: 28774496
[TBL] [Abstract][Full Text] [Related]
13. Turning the spotlight on the C11-oxy androgens in human fetal development.
du Toit T; Swart AC
J Steroid Biochem Mol Biol; 2021 Sep; 212():105946. PubMed ID: 34171490
[TBL] [Abstract][Full Text] [Related]
14. A new dawn for androgens: Novel lessons from 11-oxygenated C19 steroids.
Pretorius E; Arlt W; Storbeck KH
Mol Cell Endocrinol; 2017 Feb; 441():76-85. PubMed ID: 27519632
[TBL] [Abstract][Full Text] [Related]
15. 11β-Hydroxydihydrotestosterone and 11-ketodihydrotestosterone, novel C19 steroids with androgenic activity: a putative role in castration resistant prostate cancer?
Storbeck KH; Bloem LM; Africander D; Schloms L; Swart P; Swart AC
Mol Cell Endocrinol; 2013 Sep; 377(1-2):135-46. PubMed ID: 23856005
[TBL] [Abstract][Full Text] [Related]
16. The serum steroid signature of PCOS hints at the involvement of novel pathways for excess androgen biosynthesis.
Altinkilic EM; du Toit T; Sakin Ö; Attar R; Groessl M; Flück CE
J Steroid Biochem Mol Biol; 2023 Oct; 233():106366. PubMed ID: 37499841
[TBL] [Abstract][Full Text] [Related]
17. C11-oxy C
du Toit T; Finken MJJ; Hamer HM; Heijboer AC; Swart AC
Steroids; 2018 Oct; 138():1-5. PubMed ID: 29883615
[TBL] [Abstract][Full Text] [Related]
18. Classic and current concepts in adrenal steroidogenesis: a reappraisal.
Kater CE; Giorgi RB; Costa-Barbosa FA
Arch Endocrinol Metab; 2022 Mar; 66(1):77-87. PubMed ID: 35263051
[TBL] [Abstract][Full Text] [Related]
19. 11-Oxygenated C19 Steroids Are the Predominant Androgens in Polycystic Ovary Syndrome.
O'Reilly MW; Kempegowda P; Jenkinson C; Taylor AE; Quanson JL; Storbeck KH; Arlt W
J Clin Endocrinol Metab; 2017 Mar; 102(3):840-848. PubMed ID: 27901631
[TBL] [Abstract][Full Text] [Related]
20. 11β-Hydroxyandrostenedione: Downstream metabolism by 11βHSD, 17βHSD and SRD5A produces novel substrates in familiar pathways.
Swart AC; Storbeck KH
Mol Cell Endocrinol; 2015 Jun; 408():114-23. PubMed ID: 25542845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]